We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
Apr 26, 2019
In my opinion if the patient is not symptomatic and the nodules are stable I would continue the treatment and re-evaluate every 10-12 weeks.
Apr 26, 2019
This case cannot be discussed properly, because lots of information is missing. Patient had multiple splenic lesions and retroperitoneal lymph nodes and underwent radical nephrectomy with splenectomy. No data provided the pathological findings of surgical specimen regarding those splenic lesions. No proper data provided regarding measurements of proposed retroperitoeal lympadenopathy before the radical nephrectomy and on the latest scans, so we can't judge size changes of these lesions. We do not have the result of preoperative chest CT scan too, so we can't judge whether pulmonary nodules are novel lesions or not. It would be also useful to know, how many nodules are we talking about? 5? 10? or more? Without these data nobody can exactly asses the change of the disease, so no recommendation can be done regarding the further management.
Oct 06, 2022
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.